The Complex Orofacial Pain Patient: A Case for Collaboration Between the Orofacial Pain Dentist and the Clinical Health Psychologist

  • John L. ReevesII
  • Robert L. Merrill

This chapter presents an example of a integrated biopsychosocial collaborative relationship between a dentist board-certified in orofacial pain and a board-certified clinical health psychologist with advanced training in clinical psychopharmacology. The orofacial pain dentist and the clinical health psychologist collaborated in diagnosing and successfully treating a patient with complex chronic orofacial pain and excessive narcotic and benzodiazepine use. After reading this chapter the reader should have an appreciation of how utilizing a integrated collaborative biopsychosocial model results in a comprehensive treatment plan that guides a dynamic treatment process to optimize clinical outcome.


Trigeminal Neuralgia Trigger Point Extraction Site Myofascial Pain Borderline Personality Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965; 150(699):971–979.PubMedCrossRefGoogle Scholar
  2. 2.
    Fordyce WE. Behavioral Methods for Chronic Pain and Illness.St Louis: Mosby: 1976.Google Scholar
  3. 3.
    Thorn BE. Cognitive Therapy for Chronic Pain: A Step-By-Step Guide.New York: The Guildford Press; 2004.Google Scholar
  4. 4.
    Sammons M, Schmidt N. Combined Treatments for Mental Disorders: A Guide to Psychological Interventions. 1st ed. Washington, DC: American Psychological Association Press; 2001.Google Scholar
  5. 5.
    Simons D, Travell J, Simons L. Myofascial Pain and Dysfunction: The Trigger Point Manual. 2nd ed. Baltimore: Williams and Wilkins; 1999.Google Scholar
  6. 6.
    Vanderah TW, Suenaga NM, Ossipov MH, Malan TP Jr, Lai J, Porreca F. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci. 2001: 21(1):279–286.PubMedGoogle Scholar
  7. 7.
    Buckley F, Sizemore W, Carlton J. Medication management in patients with chronic non-malignant pain: a review of the use of a drug withdrawal protocol. Pain. 1986; 26(2):153–165.PubMedCrossRefGoogle Scholar
  8. 8.
    Ralphs J, Williams A, Richardson P, Pither C, Nicholas M. Opioid reduction in chronic pain patients. A comparison of patient-controlled reduction and staff controlled cocktail methods. Pain.1994; 56(3):279–288.PubMedCrossRefGoogle Scholar
  9. 9.
    Woolfolk R, Allen L. Treating Somatization Disorder: A Cognitive-Behavioral Approach.New York: Guildford Press; 2006.Google Scholar
  10. 10.
    Merrill R. Intraoral neuropathy. Curr Pain Headache Rep. 2004; 8:341–346.PubMedCrossRefGoogle Scholar
  11. 11.
    Padilla M, Clark G, Merrill R. Topical medications for orofacial neuropathic pain: a review. J Am Dent Assoc. 2000; 131:184–194.PubMedGoogle Scholar
  12. 12.
    Graff-Radford SB. Headache problems that can present as toothache. Dent Clin North Am. 1991; 55:155–170.Google Scholar
  13. 13.
    Penarrocha M, Bandres A, Penarrocha M, Bagan J. Lower-half facial migraine: a report of 11 cases. J Oral Maxillofac Surg. 2004; 62(12):1453–1456.PubMedCrossRefGoogle Scholar
  14. 14.
    Mathew NT, Kurman R, Perez F. Drug induced refractory headache—clinical features and management. Headache. 1990: 30(10):634–638.PubMedCrossRefGoogle Scholar
  15. 15.
    Graff-Radford SB, Reeves JL, Jaeger B. Management of chronic head and neck pain: effectiveness of altering factors perpetuating myofascial pain. Headache. 1987; 27(4):186–190.PubMedCrossRefGoogle Scholar
  16. 16.
    Simons D. Neurophysiological basis of pain caused by trigger points. J Am Pain Soc. 1994; 3(1):17–19.Google Scholar
  17. 17.
    Forsyth JP, Barrios V, Acheson DT. Exposure therapy and cognitive interventions for anxiety disorders: Overview and newer third-generation perspectives. In, Richard DCS, Lauterbach, D (eds) Handbook of Exposure Therapies. Academic Press; New York. 2006, pp. 61–108.Google Scholar
  18. 18.
    Gross JJ, John OP. Individual differences in two emotion regulation processes: implications for affect, relationships, and well-being. J Pers soc psychol, 2003; Aug; 85(2): 348–62.PubMedCrossRefGoogle Scholar
  19. 19.
    Linehan MM. Cognitive-Behavioral Treatment of Borderline Personality Disorder.New York; The Guildford Press; 1993.Google Scholar
  20. 20.
    Stone MH. Relationship of borderline personality disorder and bipolar disorder. Am J Psychiatry. 2006; 163(7):1126–1128.PubMedCrossRefGoogle Scholar
  21. 21.
    Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache. 1987; 27(2):102–106.PubMedCrossRefGoogle Scholar
  22. 22.
    Von Korff M, Galer BS, Stang P. Chronic use of symptomatic headache medications. Pain. 1995; 62(2):179–186.CrossRefGoogle Scholar
  23. 23.
    McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003; 348(26):2635–2645.PubMedCrossRefGoogle Scholar
  24. 24.
    Oakley ME, McCreary CP, Clark GT, Flack VF. Screening for psychological problems in TMD patients. J Orofacial pain. 1993; 7;143–149.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • John L. ReevesII
    • 1
  • Robert L. Merrill
    • 1
  1. 1.Section of Oral Medicine and Orofacial PainUCLA School of DentistryLos AngelesUSA

Personalised recommendations